Cytek® Biosciences Names William McCombe Chief Financial Officer
March 19, 2024 08:00 ET
|
Cytek Biosciences, Inc.
Experienced executive with extensive background as CFO for global corporations across dynamic sectors Cytek reaffirms 2024 outlook FREMONT, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Cytek...
LifeVantage Corporation to Participate in Water Tower Fireside Chat Series
March 19, 2024 08:00 ET
|
LifeVantage Corporation
SALT LAKE CITY, March 19, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes, today...
Applied Digital Among First Cloud Service Providers to Use New NVIDIA Blackwell Platform
March 19, 2024 08:00 ET
|
Applied Digital Corporation
Applied Digital to use the latest NVIDIA Blackwell platform-based GPUs for HPC applications, ensuring cutting-edge computing power for AI, machine learning, and graphics rendering. The collaboration...
Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A
March 19, 2024 08:00 ET
|
Cocrystal Pharma, Inc.
Feedback provides greater clarity on regulatory requirements for planned Phase 2b trial BOTHELL, Wash., March 19, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or...
Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China
March 19, 2024 07:55 ET
|
Clearmind Medicine Inc.
A Novel Approach to Combatting Binge Behaviors with Groundbreaking Psychedelic Therapy Tel Aviv, Israel / Vancouver, Canada, March 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq:...
Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform
March 19, 2024 07:30 ET
|
Evaxion Biotech
The proprietary AI-Immunology™ platform brings the potential for a new era in vaccine discovery, design and development using advanced AI and machine learning technologiesAI-Immunology™ outcompetes...
Repligen Appoints Maggie A. Pax to Board of Directors
March 19, 2024 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life sciences industry executive Maggie A. Pax....
InflaRx to Announce Development Plans for INF904 and 2023 Financial Results on March 21, 2024
March 19, 2024 07:30 ET
|
InflaRx N.V.
JENA, Germany, March 19, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...
Formula Systems Reports Fourth Quarter and Full Year 2023 Financial Results
March 19, 2024 07:08 ET
|
Formula Systems (1985) Ltd.
OR YEHUDA, Israel, March 19, 2024 (GLOBE NEWSWIRE) -- Or Yehuda, Israel, March 19, 2024 – Formula Systems (1985) Ltd. (Nasdaq and TASE: FORTY) (“Formula” or the “Company”), a global information...
Gilat Unveils Cloud and 5G NTN Evolution Strategy for SkyEdge IV
March 19, 2024 07:05 ET
|
Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, March 19, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services,...